Kirubel Biruk Shiferaw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kirubel Biruk Shiferaw has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Dagmar Waltemath
Medical Informatics Laboratory, University Medicine Greifswald, Greifswald, Germany
11 shared publications - Atinkut Alamirrew Zeleke
University Medicine Greifswald
7 shared publications - Irina Balaur
Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg
6 shared publications Atinkut Alamirrew Zeleke
Department of Medical Informatics, Institute for Community Medicine, University Medicine Greifswald , Greifswald D-17475
4 shared publications- Eden Abetu Mehari
Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
4 shared publications - Danielle Welter
Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg, Luxembourg
3 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Springer Nature in npj Systems Biology and Applications
A system for FAIR assessment of computational biology models and simulations based on RDA indicators
Computational models are essential for studying complex systems. We adapted the Findability, Accessibility, Interoperability, and Reusability (FAIR) indicators established by the Research Data Alliance to assess models encoded in domain-specific standards, including those developed by the COMBINE community. The resulting FAIR assessments guide FAIRification and, in turn, improve the transparent communication of a model’s features, capabilities, and provenance, particularly in clinical settings.
- 6 October 2026
- Published by Springer Nature in npj Systems Biology and Applications
Open AccessA system for FAIR assessment of computational biology models and simulations based on RDA indicators
Computational models are essential for studying complex systems. We adapted the Findability, Accessibility, Interoperability, and Reusability (FAIR) indicators established by the Research Data Alliance to assess models encoded in domain-specific standards, including those developed by the COMBINE community. The resulting FAIR assessments guide FAIRification and, in turn, improve the transparent communication of a model’s features, capabilities, and provenance, particularly in clinical settings.
- Open Access
Lessons learned from evaluating the NFDI4Health metadata schema for health studies using the Research Data Alliance’s FAIR data maturity model
Objectives: The German National Research Data Infrastructure for Personal Health Data (NFDI4Health) has developed a metadata schema (MDS) for harmonizing health study descriptions, along with a platform for content discovery. This work evaluates how well the MDS promotes FAIR data principles (Findability, Accessibility, Interoperability, Reusability) and serves as a proxy for assessing study FAIRness. Materials and Methods: Using the Research Data Alliance’s ‘FAIR data maturity model’, we assessed the scope of evaluable FAIRness indicators for NFDI4Health’s MDS (version 3.3). Results: 29 of 41 FAIRness indicators can be evaluated (Findability: 7/7, Interoperability: 7/12, Accessibility: 7/12, Reusability: 8/10). The remaining indicators relate to the research data’s format and access procedures. Discussion: The MDS provides a viable basis for evaluating study FAIRness. To enable full indicator coverage, additional metadata elements should be incorporated. Conclusion: NFDI4Health’s MDS effectively promotes FAIR-compliant study descriptions, although adjustments could strengthen its utility for assessing research data FAIRness. Lay summary: Making research data easily Findable, Accessible, Interoperable, and Reusable (FAIR) is crucial for accelerating discoveries in health research. The German National Research Data Infrastructure for Personal Health Data (NFDI4Health) is an initiative and network that develops services, tools, and training programs to promote and support the FAIR sharing of health research data in Germany. As part of this effort, NFDI4Health has created a standardized framework, referred to as metadata schema (MDS), to systematically collect and structure information about health studies. The collected information can be accessed through a dedicated platform provided by NFDI4Health. In light of ongoing developments of the platform, it is important to assess whether the MDS content may serve as a proxy for assessing the FAIRness of the included studies. Therefore, we assessed the scope of evaluable FAIRness indicators based on the ‘FAIR data maturity model’ by the Research Data Alliance. Our assessment shows that 29 of 41 FAIRness indicators can currently be evaluated. The remaining indicators relate to the data format and access procedures. However, they could be easily covered by introducing new elements to the MDS and encouraging data holders to provide the required information. Overall, the MDS effectively supports FAIR-compliant descriptions of health studies.
Open AccessLessons learned from evaluating the NFDI4Health metadata schema for health studies using the Research Data Alliance’s FAIR data maturity model
Objectives: The German National Research Data Infrastructure for Personal Health Data (NFDI4Health) has developed a metadata schema (MDS) for harmonizing health study descriptions, along with a platform for content discovery. This work evaluates how well the MDS promotes FAIR data principles (Findability, Accessibility, Interoperability, Reusability) and serves as a proxy for assessing study FAIRness. Materials and Methods: Using the Research Data Alliance’s ‘FAIR data maturity model’, we assessed the scope of evaluable FAIRness indicators for NFDI4Health’s MDS (version 3.3). Results: 29 of 41 FAIRness indicators can be evaluated (Findability: 7/7, Interoperability: 7/12, Accessibility: 7/12, Reusability: 8/10). The remaining indicators relate to the research data’s format and access procedures. Discussion: The MDS provides a viable basis for evaluating study FAIRness. To enable full indicator coverage, additional metadata elements should be incorporated. Conclusion: NFDI4Health’s MDS effectively promotes FAIR-compliant study descriptions, although adjustments could strengthen its utility for assessing research data FAIRness. Lay summary: Making research data easily Findable, Accessible, Interoperable, and Reusable (FAIR) is crucial for accelerating discoveries in health research. The German National Research Data Infrastructure for Personal Health Data (NFDI4Health) is an initiative and network that develops services, tools, and training programs to promote and support the FAIR sharing of health research data in Germany. As part of this effort, NFDI4Health has created a standardized framework, referred to as metadata schema (MDS), to systematically collect and structure information about health studies. The collected information can be accessed through a dedicated platform provided by NFDI4Health. In light of ongoing developments of the platform, it is important to assess whether the MDS content may serve as a proxy for assessing the FAIRness of the included studies. Therefore, we assessed the scope of evaluable FAIRness indicators based on the ‘FAIR data maturity model’ by the Research Data Alliance. Our assessment shows that 29 of 41 FAIRness indicators can currently be evaluated. The remaining indicators relate to the data format and access procedures. However, they could be easily covered by introducing new elements to the MDS and encouraging data holders to provide the required information. Overall, the MDS effectively supports FAIR-compliant descriptions of health studies.
- Open Access
Calibrating CONSORT-AI with FAIR Principles to enhance reproducibility in AI-driven clinical trials
: Artificial intelligence (AI) is increasingly embedded in clinical trials, yet poor reproducibility remains a critical barrier to trustworthy and transparent research. In this study, we propose a structured calibration of the CONSORT-AI reporting guideline using the FAIR (Findable, Accessible, Interoperable, Reusable) principles. We introduce the application of CALIFRAME, a framework designed to evaluate and align existing medical AI reporting standards with FAIR-compliant practices. Applying CALIFRAME to the CONSORT-AI checklist reveals specific gaps in data and code sharing, metadata use, and accessibility practices in current AI-driven clinical trials. Our results underscore the need for standardized metadata, clear licensing, and stakeholder-inclusive design in medical AI reporting. We demonstrate that FAIR- oriented calibration of reporting guidelines can bridge the reproducibility gap and support more transparent, efficient, and reusable AI interventions in healthcare. This work advocates for a shift toward reproducibility as a foundation for trustworthy AI in clinical research.
Open AccessCalibrating CONSORT-AI with FAIR Principles to enhance reproducibility in AI-driven clinical trials
: Artificial intelligence (AI) is increasingly embedded in clinical trials, yet poor reproducibility remains a critical barrier to trustworthy and transparent research. In this study, we propose a structured calibration of the CONSORT-AI reporting guideline using the FAIR (Findable, Accessible, Interoperable, Reusable) principles. We introduce the application of CALIFRAME, a framework designed to evaluate and align existing medical AI reporting standards with FAIR-compliant practices. Applying CALIFRAME to the CONSORT-AI checklist reveals specific gaps in data and code sharing, metadata use, and accessibility practices in current AI-driven clinical trials. Our results underscore the need for standardized metadata, clear licensing, and stakeholder-inclusive design in medical AI reporting. We demonstrate that FAIR- oriented calibration of reporting guidelines can bridge the reproducibility gap and support more transparent, efficient, and reusable AI interventions in healthcare. This work advocates for a shift toward reproducibility as a foundation for trustworthy AI in clinical research.
- Open Access
FAIRification of computational models in biology
Computational models are essential for studying complex systems which, particularly in clinical settings, need to be quality-approved and transparent. To enhance the communication of a model’s features and capabilities, we propose an adaptation of the Findability, Accessibility, Interoperability and Reusability (FAIR) indicators published by the Research Data Alliance to assess models encoded in domain-specific standards, such as those established by COMBINE. The assessments guide FAIRification and add value to models.
Open AccessFAIRification of computational models in biology
Computational models are essential for studying complex systems which, particularly in clinical settings, need to be quality-approved and transparent. To enhance the communication of a model’s features and capabilities, we propose an adaptation of the Findability, Accessibility, Interoperability and Reusability (FAIR) indicators published by the Research Data Alliance to assess models encoded in domain-specific standards, such as those established by COMBINE. The assessments guide FAIRification and add value to models.
- Open Access
- 26 December 2024
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 8 (1) , ooae155
Guidelines and standard frameworks for artificial intelligence in medicine: a systematic review
Objectives: The continuous integration of artificial intelligence (AI) into clinical settings requires the development of up-to-date and robust guidelines and standard frameworks that consider the evolving challenges of AI implementation in medicine. This review evaluates the quality of these guideline and summarizes ethical frameworks, best practices, and recommendations. Materials and Methods: The Appraisal of Guidelines, Research, and Evaluation II tool was used to assess the quality of guidelines based on 6 domains: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. The protocol of this review including the eligibility criteria, the search strategy data extraction sheet and methods, was published prior to the actual review with International Registered Report Identifier of DERR1-10.2196/47105. Results: The initial search resulted in 4975 studies from 2 databases and 7 studies from manual search. Eleven articles were selected for data extraction based on the eligibility criteria. We found that while guidelines generally excel in scope, purpose, and editorial independence, there is significant variability in applicability and the rigor of guideline development. Well-established initiatives such as TRIPOD+AI, DECIDE-AI, SPIRIT-AI, and CONSORT-AI have shown high quality, particularly in terms of stakeholder involvement. However, applicability remains a prominent challenge among the guidelines. The result also showed that the reproducibility, ethical, and environmental aspects of AI in medicine still need attention from both medical and AI communities. Discussion: Our work highlights the need for working toward the development of integrated and comprehensive reporting guidelines that adhere to the principles of Findability, Accessibility, Interoperability and Reusability. This alignment is essential for fostering a cultural shift toward transparency and open science, which are pivotal milestone for sustainable digital health research. Conclusion: This review evaluates the current reporting guidelines, discussing their advantages as well as challenges and limitations.
- 26 December 2024
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 8 (1) , ooae155
Open AccessGuidelines and standard frameworks for artificial intelligence in medicine: a systematic review
Objectives: The continuous integration of artificial intelligence (AI) into clinical settings requires the development of up-to-date and robust guidelines and standard frameworks that consider the evolving challenges of AI implementation in medicine. This review evaluates the quality of these guideline and summarizes ethical frameworks, best practices, and recommendations. Materials and Methods: The Appraisal of Guidelines, Research, and Evaluation II tool was used to assess the quality of guidelines based on 6 domains: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. The protocol of this review including the eligibility criteria, the search strategy data extraction sheet and methods, was published prior to the actual review with International Registered Report Identifier of DERR1-10.2196/47105. Results: The initial search resulted in 4975 studies from 2 databases and 7 studies from manual search. Eleven articles were selected for data extraction based on the eligibility criteria. We found that while guidelines generally excel in scope, purpose, and editorial independence, there is significant variability in applicability and the rigor of guideline development. Well-established initiatives such as TRIPOD+AI, DECIDE-AI, SPIRIT-AI, and CONSORT-AI have shown high quality, particularly in terms of stakeholder involvement. However, applicability remains a prominent challenge among the guidelines. The result also showed that the reproducibility, ethical, and environmental aspects of AI in medicine still need attention from both medical and AI communities. Discussion: Our work highlights the need for working toward the development of integrated and comprehensive reporting guidelines that adhere to the principles of Findability, Accessibility, Interoperability and Reusability. This alignment is essential for fostering a cultural shift toward transparency and open science, which are pivotal milestone for sustainable digital health research. Conclusion: This review evaluates the current reporting guidelines, discussing their advantages as well as challenges and limitations.
- Open Access
- 8 October 2024
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 7 (4) , ooae105
CALIFRAME: a proposed method of calibrating reporting guidelines with FAIR principles to foster reproducibility of AI research in medicine
Background: Procedural and reporting guidelines are crucial in framing scientific practices and communications among researchers and the broader community. These guidelines aim to ensure transparency, reproducibility, and reliability in scientific research. Despite several methodological frameworks proposed by various initiatives to foster reproducibility, challenges such as data leakage and reproducibility remain prevalent. Recent studies have highlighted the transformative potential of incorporating the FAIR (Findable, Accessible, Interoperable, and Reusable) principles into workflows, particularly in contexts like software and machine learning model development, to promote open science. Objective: This study aims to introduce a comprehensive framework, designed to calibrate existing reporting guidelines against the FAIR principles. The goal is to enhance reproducibility and promote open science by integrating these principles into the scientific reporting process. Methods: We employed the “Best fit” framework synthesis approach which involves systematically reviewing and synthesizing existing frameworks and guidelines to identify best practices and gaps. We then proposed a series of defined workflows to align reporting guidelines with FAIR principles. A use case was developed to demonstrate the practical application of the framework. Results: The integration of FAIR principles with established reporting guidelines through the framework effectively bridges the gap between FAIR metrics and traditional reporting standards. The framework provides a structured approach to enhance the findability, accessibility, interoperability, and reusability of scientific data and outputs. The use case demonstrated the practical benefits of the framework, showing improved data management and reporting practices. Discussion: The framework addresses critical challenges in scientific research, such as data leakage and reproducibility issues. By embedding FAIR principles into reporting guidelines, the framework ensures that scientific outputs are more transparent, reliable, and reusable. This integration not only benefits researchers by improving data management practices but also enhances the overall scientific process by promoting open science and collaboration. Conclusion: The proposed framework successfully combines FAIR principles with reporting guidelines, offering a robust solution to enhance reproducibility and open science. This framework can be applied across various contexts, including software and machine learning model development stages, to foster a more transparent and collaborative scientific environment.
- 8 October 2024
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 7 (4) , ooae105
Open AccessCALIFRAME: a proposed method of calibrating reporting guidelines with FAIR principles to foster reproducibility of AI research in medicine
Background: Procedural and reporting guidelines are crucial in framing scientific practices and communications among researchers and the broader community. These guidelines aim to ensure transparency, reproducibility, and reliability in scientific research. Despite several methodological frameworks proposed by various initiatives to foster reproducibility, challenges such as data leakage and reproducibility remain prevalent. Recent studies have highlighted the transformative potential of incorporating the FAIR (Findable, Accessible, Interoperable, and Reusable) principles into workflows, particularly in contexts like software and machine learning model development, to promote open science. Objective: This study aims to introduce a comprehensive framework, designed to calibrate existing reporting guidelines against the FAIR principles. The goal is to enhance reproducibility and promote open science by integrating these principles into the scientific reporting process. Methods: We employed the “Best fit” framework synthesis approach which involves systematically reviewing and synthesizing existing frameworks and guidelines to identify best practices and gaps. We then proposed a series of defined workflows to align reporting guidelines with FAIR principles. A use case was developed to demonstrate the practical application of the framework. Results: The integration of FAIR principles with established reporting guidelines through the framework effectively bridges the gap between FAIR metrics and traditional reporting standards. The framework provides a structured approach to enhance the findability, accessibility, interoperability, and reusability of scientific data and outputs. The use case demonstrated the practical benefits of the framework, showing improved data management and reporting practices. Discussion: The framework addresses critical challenges in scientific research, such as data leakage and reproducibility issues. By embedding FAIR principles into reporting guidelines, the framework ensures that scientific outputs are more transparent, reliable, and reusable. This integration not only benefits researchers by improving data management practices but also enhances the overall scientific process by promoting open science and collaboration. Conclusion: The proposed framework successfully combines FAIR principles with reporting guidelines, offering a robust solution to enhance reproducibility and open science. This framework can be applied across various contexts, including software and machine learning model development stages, to foster a more transparent and collaborative scientific environment.
- Open Access
- 23 July 2024
- Published by MDPI AG in Preprints.org
CALIFRAME: A Proposed Method of Calibrating Reporting Guidelines with FAIR Principles to Foster Reproducibility of AI Research in Medicine
Procedural and reporting guidelines frame the process of scientific practices and communications among researchers and the community at large. In the pursuit of fostering reproducibility, several methodological frameworks have been proposed by several initiatives. Nevertheless, recent studies indicate that data leakage and reproducibility are still prominent challenges. Recent studies have shown the transforming potential of incorporating the FAIR (Findable, Accessible, Interoperable and Reusable) principles in the work-flow of different context such as software and machine learning model development stages to cultivate open science. In this work, we introduce a framework to calibrate reporting guidelines against the FAIR principles in order to foster reproducibility and open science. We adapted the “Best fit” framework synthesis approach to develop the calibration framework. We propose a series of defined workflows to calibrate reporting guidelines with FAIR principles and a use case to demonstrate the process. By integrating FAIR principles with established reporting guidelines, the proposed framework bridges the gap in accommodating both FAIR metrics and reporting guidelines and benefits from advantages of these major integrated components.
- 23 July 2024
- Published by MDPI AG in Preprints.org
Open AccessCALIFRAME: A Proposed Method of Calibrating Reporting Guidelines with FAIR Principles to Foster Reproducibility of AI Research in Medicine
Procedural and reporting guidelines frame the process of scientific practices and communications among researchers and the community at large. In the pursuit of fostering reproducibility, several methodological frameworks have been proposed by several initiatives. Nevertheless, recent studies indicate that data leakage and reproducibility are still prominent challenges. Recent studies have shown the transforming potential of incorporating the FAIR (Findable, Accessible, Interoperable and Reusable) principles in the work-flow of different context such as software and machine learning model development stages to cultivate open science. In this work, we introduce a framework to calibrate reporting guidelines against the FAIR principles in order to foster reproducibility and open science. We adapted the “Best fit” framework synthesis approach to develop the calibration framework. We propose a series of defined workflows to calibrate reporting guidelines with FAIR principles and a use case to demonstrate the process. By integrating FAIR principles with established reporting guidelines, the proposed framework bridges the gap in accommodating both FAIR metrics and reporting guidelines and benefits from advantages of these major integrated components.
- Open Access
Guidelines and Standard Frameworks for Artificial Intelligence in Medicine: A Systematic Review
A growing volume of evidence marks the potential of Artificial Intelligence (AI) in medicine, in improving diagnostic accuracy, clinical decision support, risk/event prediction, drug discovery, and patient management. However, the continuous integration of AI into clinical settings requires the development of up-to-date and robust guidelines and standard frameworks that consider the evolving challenges of AI implementation in medicine. This review evaluates these guidelines’ quality and summarizes ethical frameworks, best practices, and recommendations. The Appraisal of Guidelines, Research, and Evaluation (AGREE II) tool was used to assess the quality of guidelines based on six domains: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. The protocol of this review including the eligibility criteria, the search strategy data extraction sheet and methods, was published prior to the actual review with International Registered Report Identifier (IRRID) of ( DERR1-10.2196/47105). The initial search resulted in 4,975 studies from two databases and five studies from manual search. Nine articles were selected for data extraction based on the eligibility criteria. We found that while guidelines generally excel in scope, purpose, and editorial independence, there is significant variability in applicability and the rigour of guideline development. Well-established initiatives such as DECIDE-AI, SPIRIT-AI, and CONSORT-AI have shown high quality, particularly in terms of stakeholder involvement. However, applicability remains a prominent challenge among the guidelines. We conclude that the reproducibility, ethical and environmental aspects of AI in medicine still need attention from both medical and AI communities. This review emphasizes the crucial need for high-quality guidelines and opens a new avenue in evaluating guidelines themselves. Our work highlights the need for working toward the development of integrated and comprehensive reporting guidelines that adhere to the principles of Findability, Accessibility, Interoperability and Reusability (FAIR). This alignment is essential for fostering a cultural shift towards transparency and open science, which are pivotal milestone for sustainable digital health research.
Open AccessGuidelines and Standard Frameworks for Artificial Intelligence in Medicine: A Systematic Review
A growing volume of evidence marks the potential of Artificial Intelligence (AI) in medicine, in improving diagnostic accuracy, clinical decision support, risk/event prediction, drug discovery, and patient management. However, the continuous integration of AI into clinical settings requires the development of up-to-date and robust guidelines and standard frameworks that consider the evolving challenges of AI implementation in medicine. This review evaluates these guidelines’ quality and summarizes ethical frameworks, best practices, and recommendations. The Appraisal of Guidelines, Research, and Evaluation (AGREE II) tool was used to assess the quality of guidelines based on six domains: scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence. The protocol of this review including the eligibility criteria, the search strategy data extraction sheet and methods, was published prior to the actual review with International Registered Report Identifier (IRRID) of ( DERR1-10.2196/47105). The initial search resulted in 4,975 studies from two databases and five studies from manual search. Nine articles were selected for data extraction based on the eligibility criteria. We found that while guidelines generally excel in scope, purpose, and editorial independence, there is significant variability in applicability and the rigour of guideline development. Well-established initiatives such as DECIDE-AI, SPIRIT-AI, and CONSORT-AI have shown high quality, particularly in terms of stakeholder involvement. However, applicability remains a prominent challenge among the guidelines. We conclude that the reproducibility, ethical and environmental aspects of AI in medicine still need attention from both medical and AI communities. This review emphasizes the crucial need for high-quality guidelines and opens a new avenue in evaluating guidelines themselves. Our work highlights the need for working toward the development of integrated and comprehensive reporting guidelines that adhere to the principles of Findability, Accessibility, Interoperability and Reusability (FAIR). This alignment is essential for fostering a cultural shift towards transparency and open science, which are pivotal milestone for sustainable digital health research.
- Open Access
- 3 January 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1308668
Navigating the AI frontiers in cardiovascular research: a bibliometric exploration and topic modeling
Artificial intelligence (AI) has emerged as a promising field in cardiovascular disease (CVD) research, offering innovative approaches to enhance diagnosis, treatment, and patient outcomes. In this study, we conducted bibliometric analysis combined with topic modeling to provide a comprehensive overview of the AI research landscape in CVD. Our analysis included 23,846 studies from Web of Science and PubMed, capturing the latest advancements and trends in this rapidly evolving field. By employing LDA (Latent Dirichlet Allocation) we identified key research themes, trends, and collaborations within the AI-CVD domain.The findings revealed the exponential growth of AI-related research in CVD, underscoring its immense potential to revolutionize cardiovascular healthcare. The annual scientific publication of machine learning papers in CVD increases continuously and significantly since 2016, with an overall annual growth rate of 22.8%. Almost half (46.2%) of the growth happened in the last 5 years. USA, China, India, UK and Korea were the top five productive countries in number of publications. UK, Germany and Australia were the most collaborative countries with a multiple country publication (MCP) value of 42.8%, 40.3% and 40.0% respectively. We observed the emergence of twenty-two distinct research topics, including “stroke and robotic rehabilitation therapy,” “robotic-assisted cardiac surgery,” and “cardiac image analysis,” which persisted as major topics throughout the years. Other topics, such as “retinal image analysis and CVD” and “biomarker and wearable signal analyses,” have recently emerged as dominant areas of research in cardiovascular medicine.Convolutional neural network appears to be the most mentioned algorithm followed by LSTM (Long Short-Term Memory) and KNN (K-Nearest Neighbours). This indicates that the future direction of AI cardiovascular research is predominantly directing toward neural networks and image analysis.As AI continues to shape the landscape of CVD research, our study serves as a comprehensive guide for researchers, practitioners, and policymakers, providing valuable insights into the current state of AI in CVD research. This study offers a deep understanding of research trends and paves the way for future directions to maximiz the potential of AI to effectively combat cardiovascular diseases.
- 3 January 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1308668
Open AccessNavigating the AI frontiers in cardiovascular research: a bibliometric exploration and topic modeling
Artificial intelligence (AI) has emerged as a promising field in cardiovascular disease (CVD) research, offering innovative approaches to enhance diagnosis, treatment, and patient outcomes. In this study, we conducted bibliometric analysis combined with topic modeling to provide a comprehensive overview of the AI research landscape in CVD. Our analysis included 23,846 studies from Web of Science and PubMed, capturing the latest advancements and trends in this rapidly evolving field. By employing LDA (Latent Dirichlet Allocation) we identified key research themes, trends, and collaborations within the AI-CVD domain.The findings revealed the exponential growth of AI-related research in CVD, underscoring its immense potential to revolutionize cardiovascular healthcare. The annual scientific publication of machine learning papers in CVD increases continuously and significantly since 2016, with an overall annual growth rate of 22.8%. Almost half (46.2%) of the growth happened in the last 5 years. USA, China, India, UK and Korea were the top five productive countries in number of publications. UK, Germany and Australia were the most collaborative countries with a multiple country publication (MCP) value of 42.8%, 40.3% and 40.0% respectively. We observed the emergence of twenty-two distinct research topics, including “stroke and robotic rehabilitation therapy,” “robotic-assisted cardiac surgery,” and “cardiac image analysis,” which persisted as major topics throughout the years. Other topics, such as “retinal image analysis and CVD” and “biomarker and wearable signal analyses,” have recently emerged as dominant areas of research in cardiovascular medicine.Convolutional neural network appears to be the most mentioned algorithm followed by LSTM (Long Short-Term Memory) and KNN (K-Nearest Neighbours). This indicates that the future direction of AI cardiovascular research is predominantly directing toward neural networks and image analysis.As AI continues to shape the landscape of CVD research, our study serves as a comprehensive guide for researchers, practitioners, and policymakers, providing valuable insights into the current state of AI in CVD research. This study offers a deep understanding of research trends and paves the way for future directions to maximiz the potential of AI to effectively combat cardiovascular diseases.
- Open Access
- 25 October 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e47105
Guidelines and Standard Frameworks for AI in Medicine: Protocol for a Systematic Literature Review
Background: Applications of artificial intelligence (AI) are pervasive in modern biomedical science. In fact, research results suggesting algorithms and AI models for different target diseases and conditions are continuously increasing. While this situation undoubtedly improves the outcome of AI models, health care providers are increasingly unsure which AI model to use due to multiple alternatives for a specific target and the “black box” nature of AI. Moreover, the fact that studies rarely use guidelines in developing and reporting AI models poses additional challenges in trusting and adapting models for practical implementation. Objective: This review protocol describes the planned steps and methods for a review of the synthesized evidence regarding the quality of available guidelines and frameworks to facilitate AI applications in medicine. Methods: We will commence a systematic literature search using medical subject headings terms for medicine, guidelines, and machine learning (ML). All available guidelines, standard frameworks, best practices, checklists, and recommendations will be included, irrespective of the study design. The search will be conducted on web-based repositories such as PubMed, Web of Science, and the EQUATOR (Enhancing the Quality and Transparency of Health Research) network. After removing duplicate results, a preliminary scan for titles will be done by 2 reviewers. After the first scan, the reviewers will rescan the selected literature for abstract review, and any incongruities about whether to include the article for full-text review or not will be resolved by the third and fourth reviewer based on the predefined criteria. A Google Scholar (Google LLC) search will also be performed to identify gray literature. The quality of identified guidelines will be evaluated using the Appraisal of Guidelines, Research, and Evaluation (AGREE II) tool. A descriptive summary and narrative synthesis will be carried out, and the details of critical appraisal and subgroup synthesis findings will be presented. Results: The results will be reported using the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) reporting guidelines. Data analysis is currently underway, and we anticipate finalizing the review by November 2023. Conclusions: Guidelines and recommended frameworks for developing, reporting, and implementing AI studies have been developed by different experts to facilitate the reliable assessment of validity and consistent interpretation of ML models for medical applications. We postulate that a guideline supports the assessment of an ML model only if the quality and reliability of the guideline are high. Assessing the quality and aspects of available guidelines, recommendations, checklists, and frameworks—as will be done in the proposed review—will provide comprehensive insights into current gaps and help to formulate future research directions. International Registered Report Identifier (IRRID): DERR1-10.2196/47105
- 25 October 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e47105
Open AccessGuidelines and Standard Frameworks for AI in Medicine: Protocol for a Systematic Literature Review
Background: Applications of artificial intelligence (AI) are pervasive in modern biomedical science. In fact, research results suggesting algorithms and AI models for different target diseases and conditions are continuously increasing. While this situation undoubtedly improves the outcome of AI models, health care providers are increasingly unsure which AI model to use due to multiple alternatives for a specific target and the “black box” nature of AI. Moreover, the fact that studies rarely use guidelines in developing and reporting AI models poses additional challenges in trusting and adapting models for practical implementation. Objective: This review protocol describes the planned steps and methods for a review of the synthesized evidence regarding the quality of available guidelines and frameworks to facilitate AI applications in medicine. Methods: We will commence a systematic literature search using medical subject headings terms for medicine, guidelines, and machine learning (ML). All available guidelines, standard frameworks, best practices, checklists, and recommendations will be included, irrespective of the study design. The search will be conducted on web-based repositories such as PubMed, Web of Science, and the EQUATOR (Enhancing the Quality and Transparency of Health Research) network. After removing duplicate results, a preliminary scan for titles will be done by 2 reviewers. After the first scan, the reviewers will rescan the selected literature for abstract review, and any incongruities about whether to include the article for full-text review or not will be resolved by the third and fourth reviewer based on the predefined criteria. A Google Scholar (Google LLC) search will also be performed to identify gray literature. The quality of identified guidelines will be evaluated using the Appraisal of Guidelines, Research, and Evaluation (AGREE II) tool. A descriptive summary and narrative synthesis will be carried out, and the details of critical appraisal and subgroup synthesis findings will be presented. Results: The results will be reported using the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) reporting guidelines. Data analysis is currently underway, and we anticipate finalizing the review by November 2023. Conclusions: Guidelines and recommended frameworks for developing, reporting, and implementing AI studies have been developed by different experts to facilitate the reliable assessment of validity and consistent interpretation of ML models for medical applications. We postulate that a guideline supports the assessment of an ML model only if the quality and reliability of the guideline are high. Assessing the quality and aspects of available guidelines, recommendations, checklists, and frameworks—as will be done in the proposed review—will provide comprehensive insights into current gaps and help to formulate future research directions. International Registered Report Identifier (IRRID): DERR1-10.2196/47105